Oscar Health Inc has a market cap of $3.51 billion and is expected to release its quarterly earnings report in July.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 2.86B, with a low of 2.72B and a high of 3B. The median projection represents growth squeezing down to 29.05% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 11.24B, or 22.48% up from figures reported last year.
On the other hand, looking at the outlook for the OSCR stock, short term indicators assign the stock an average of Hold, while medium term indicators assign it an average of 100% Sell.
Based on estimates by 5 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 2 have rated the Oscar Health Inc (OSCR) stock as a Hold, while 3 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note that the PEG ratio for the OSCR stock currently stands at 0.30, and the current price level is -10.37% off its SMA20 and -0.12% from its 50-day simple moving average. The RSI (14) is pointing at 43.40 while the volatility over the past week is 5.54% and jumps to 7.17% over the past one month. The beta value is 1.73, while the average true range (ATR) is currently pointing at 0.95. The average price target for the stock over the next 12 months is $21, with the estimates having a low of $5 and a high of $28. These price ends are 63.77% and -102.9% off the current price level respectively, although investors could be excited at the prospect of a -52.17% if the OSCR share price touches on the median price of $21.
